MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ane.13332

Медицинская библиотека · Acta neurologica Scandinavica · 2020

Thymomatous myasthenia gravis: 10-year experience of a single center.

Chen Jiaxin, Shang Wenjin, Chen Yin, Li Yan, Huang Xin, Su Chunhua, Zhu Kai, Zhang Jieni, Liu Weibin, Feng Huiyu

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

To summarize the clinical features of thymomatous myasthenia gravis (T-MG), examine the association between MG and thymoma, and identify the related factors or predictors for long-term prognosis of T-MG.

METHODS

A retrospective, observational study was conducted on 100 patients with T-MG and 96 patients with non-T-MG (NT-MG) between January 1, 2009 and December 31, 2019. The baseline characteristics were recorded for each patient. Logistic regression was used to measure the association between all clinical variables and T-MG prognosis.

RESULTS

Between the T-MG and NT-MG groups, age at onset (45.66 ± 11.53 years vs 39.06 ± 14.39 years); age >40 years (72.0% vs. 40.6%); AChR-Ab positive rate (100.0% vs. 83.3%); Myasthenia Gravis Foundation of America (MGFA) classification at the worst condition (≥grade III, 61.0% vs. 33.0%); thyroid dysfunction (7.0% vs. 20.8%); and outcome (complete stable remission + pharmacologic remission + improvement, 74.0% vs. 93.7%) were statistically significant (P < .05). Presence of thymoma (OR = 0.196, 95%CI = 0.076-0.511, P = .001) was a risk factor for MG. Male sex, post-operative complications, higher grade of MGFA classification, and thymoma Masaoka-Koga pathological stage were risk predictors for long-term prognosis of T-MG (P < .1). Use of preoperative anticholinesterase drugs (OR = 5.504, 95%CI = 1.424-21.284, P = .013) was identified as an independent predictor for T-MG.

CONCLUSION

T-MG is clinically different from NT-MG, and thymoma is considered a risk factor for MG. Preoperative anticholinesterase drug use is a protective factor for long-term prognosis of T-MG. A comprehensive understanding of the characteristics of T-MG will likely help improve its prognosis.

Для цитирования: Chen Jiaxin, Shang Wenjin, Chen Yin, Li Yan, Huang Xin, Su Chunhua, Zhu Kai, Zhang Jieni, Liu Weibin, Feng Huiyu. Thymomatous myasthenia gravis: 10-year experience of a single center.. Acta neurologica Scandinavica. 2020. DOI: 10.1111/ane.13332.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.